{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T02:41:30Z","timestamp":1793328090061,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T00:00:00Z","timestamp":1710979200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["897185"],"award-info":[{"award-number":["897185"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["18PRE33960396"],"award-info":[{"award-number":["18PRE33960396"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["R15HL145573"],"award-info":[{"award-number":["R15HL145573"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007813","name":"Center for AIDS Research, University of Washington","doi-asserted-by":"publisher","award":["P30AI036219"],"award-info":[{"award-number":["P30AI036219"]}],"id":[{"id":"10.13039\/100007813","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"NIA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"NHLBI","doi-asserted-by":"publisher","award":["F31HL162548"],"award-info":[{"award-number":["F31HL162548"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"NHLBI","doi-asserted-by":"publisher","award":["HL154026"],"award-info":[{"award-number":["HL154026"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"NHLBI","doi-asserted-by":"publisher","award":["HL098217"],"award-info":[{"award-number":["HL098217"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jtha.2024.03.004","type":"journal-article","created":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T22:55:59Z","timestamp":1710802559000},"page":"1715-1726","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["A mouse model of the protease-activated receptor 4 Pro310Leu variant has reduced platelet reactivity"],"prefix":"10.1016","volume":"22","author":[{"given":"Xu","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Knauss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria de la","family":"Fuente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald A.","family":"Conlon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David F.","family":"LePage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie A.","family":"Renna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven E.","family":"McKenzie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marvin T.","family":"Nieman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2024.03.004_bib1","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.blre.2011.03.002","article-title":"Platelets at work in primary hemostasis","volume":"25","author":"Broos","year":"2011","journal-title":"Blood Rev"},{"key":"10.1016\/j.jtha.2024.03.004_bib2","doi-asserted-by":"crossref","first-page":"18S","DOI":"10.1378\/chest.124.3_suppl.18S","article-title":"Thrombin and platelet activation","volume":"124","author":"Brass","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.jtha.2024.03.004_bib3","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.thromres.2020.08.004","article-title":"The domino effect triggered by the tethered ligand of the protease activated receptors","volume":"196","author":"Han","year":"2020","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2024.03.004_bib4","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1172\/JCI6042","article-title":"Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin","volume":"103","author":"Kahn","year":"1999","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jtha.2024.03.004_bib5","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/0092-8674(91)90261-V","article-title":"Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation","volume":"64","author":"Vu","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.jtha.2024.03.004_bib6","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1182\/blood-2015-11-636472","article-title":"Protease-activated receptors in hemostasis","volume":"128","author":"Nieman","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.03.004_bib7","doi-asserted-by":"crossref","first-page":"21619","DOI":"10.1074\/jbc.270.37.21619","article-title":"Mechanisms of thrombin receptor agonist specificity. Chimeric receptors and complementary mutations identify an agonist recognition site","volume":"270","author":"Nanevicz","year":"1995","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jtha.2024.03.004_bib8","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1021\/bi9927078","article-title":"Biphasic kinetics of activation and signaling for PAR1 and PAR4 thrombin receptors in platelets","volume":"39","author":"Covic","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.jtha.2024.03.004_bib9","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1111\/j.1538-7836.2005.01377.x","article-title":"Protease-activated receptors in hemostasis, thrombosis and vascular biology","volume":"3","author":"Coughlin","year":"2005","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.03.004_bib10","doi-asserted-by":"crossref","first-page":"6642","DOI":"10.1073\/pnas.95.12.6642","article-title":"Cloning and characterization of human protease-activated receptor 4","volume":"95","author":"Xu","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtha.2024.03.004_bib11","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1111\/jth.13293","article-title":"Inhibition of protease-activated receptor 4 impairs platelet procoagulant activity during thrombus formation in human blood","volume":"14","author":"French","year":"2016","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.03.004_bib12","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf5294","article-title":"Blockade of protease-activated receptor-4 (PAR4) provides robust antithrombotic activity with low bleeding","volume":"9","author":"Wong","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jtha.2024.03.004_bib13","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1161\/ATVBAHA.117.310104","article-title":"PAR4 (protease-activated receptor 4) antagonism with BMS-986120 inhibits human ex\u00a0vivo thrombus formation","volume":"38","author":"Wilson","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtha.2024.03.004_bib14","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1056\/NEJMoa1200933","article-title":"Vorapaxar in the secondary prevention of atherothrombotic events","volume":"366","author":"Morrow","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2024.03.004_bib15","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1109719","article-title":"Thrombin-receptor antagonist vorapaxar in acute coronary syndromes","volume":"366","author":"Tricoci","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2024.03.004_bib16","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1124\/mol.112.083477","article-title":"Protease-activated receptor (PAR) 1 and PAR4 differentially regulate factor V expression from human platelets","volume":"83","author":"Duvernay","year":"2013","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jtha.2024.03.004_bib17","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1111\/bph.13455","article-title":"Protease-activated receptor 4: from structure to function and back again","volume":"173","author":"French","year":"2016","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jtha.2024.03.004_bib18","doi-asserted-by":"crossref","first-page":"8843","DOI":"10.1021\/acs.jmedchem.2c00359","article-title":"Discovery of two novel antiplatelet clinical candidates (BMS-986120 and BMS-986141) that antagonize protease-activated receptor 4","volume":"65","author":"Priestley","year":"2022","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.jtha.2024.03.004_bib19","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1182\/blood.2019004634","article-title":"PAR4 activation involves extracellular loop 3 and transmembrane residue Thr153","volume":"136","author":"Han","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.03.004_bib20","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1182\/blood-2014-04-572479","article-title":"Common variants in the human platelet PAR4 thrombin receptor alter platelet function and differ by race","volume":"124","author":"Edelstein","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.03.004_bib21","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1182\/bloodadvances.2017015552","article-title":"A\u00a0function-blocking PAR4 antibody is markedly antithrombotic in the face of a hyperreactive PAR4 variant","volume":"2","author":"French","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2024.03.004_bib22","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1161\/ATVBAHA.118.311112","article-title":"Genetic variant in human PAR (protease-activated receptor) 4 enhances thrombus formation resulting in resistance to antiplatelet therapeutics","volume":"38","author":"Tourdot","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtha.2024.03.004_bib23","doi-asserted-by":"crossref","DOI":"10.1172\/JCI169608","article-title":"The predominant PAR4 variant in individuals of African ancestry worsens murine and human stroke outcomes","volume":"133","author":"Denorme","year":"2023","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jtha.2024.03.004_bib24","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/s41586-020-2494-3","article-title":"Suppression of proteolipid protein rescues Pelizaeus-Merzbacher disease","volume":"585","author":"Elitt","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jtha.2024.03.004_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0072457","article-title":"Total protein analysis as a reliable loading control for quantitative fluorescent western blotting","volume":"8","author":"Eaton","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.jtha.2024.03.004_bib26","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jneumeth.2008.05.003","article-title":"The use of total protein stains as loading controls: an alternative to high-abundance single-protein controls in semi-quantitative immunoblotting","volume":"172","author":"Aldridge","year":"2008","journal-title":"J\u00a0Neurosci Methods"},{"key":"10.1016\/j.jtha.2024.03.004_bib27","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ab.2013.05.027","article-title":"Stain-free total protein staining is a superior loading control to \u03b2-actin for Western blots","volume":"440","author":"Gilda","year":"2013","journal-title":"Anal Biochem"},{"key":"10.1016\/j.jtha.2024.03.004_bib28","article-title":"Ferric chloride-induced murine thrombosis models","author":"Li","year":"2016","journal-title":"J\u00a0Vis Exp"},{"key":"10.1016\/j.jtha.2024.03.004_bib29","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.redox.2012.11.001","article-title":"Ferric chloride-induced murine carotid arterial injury: a model of redox pathology","volume":"1","author":"Li","year":"2013","journal-title":"Redox Biol"},{"key":"10.1016\/j.jtha.2024.03.004_bib30","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1073\/pnas.0610188104","article-title":"Par4 is required for platelet thrombus propagation but not fibrin generation in a mouse model of thrombosis","volume":"104","author":"Vandendries","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtha.2024.03.004_bib31","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/35092573","article-title":"Role of thrombin signalling in platelets in haemostasis and thrombosis","volume":"413","author":"Sambrano","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.jtha.2024.03.004_bib32","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/rth2.12454","article-title":"Protease-activated receptors: an illustrated review","volume":"5","author":"Han","year":"2021","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.03.004_bib33","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1021\/acs.biochem.9b00987","article-title":"Expression and purification of protease-activated receptor 4 (PAR4) and analysis with histidine Hydrogen\u2013deuterium exchange","volume":"59","author":"de la Fuente","year":"2020","journal-title":"Biochemistry"},{"key":"10.1016\/j.jtha.2024.03.004_bib34","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1182\/blood.2019000435","article-title":"Genomic and transcriptomic association studies identify 16 novel susceptibility loci for venous thromboembolism","volume":"134","author":"Lindstr\u00f6m","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.03.004_bib35","doi-asserted-by":"crossref","first-page":"13279","DOI":"10.1021\/bi801334s","article-title":"Protease-activated receptor 4 uses anionic residues to interact with \u03b1-thrombin in the absence or presence of protease-activated receptor 1","volume":"47","author":"Nieman","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.jtha.2024.03.004_bib36","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1161\/CIRCULATIONAHA.105.587758","article-title":"Blocking the protease-activated receptor 1-4 heterodimer in platelet-mediated thrombosis","volume":"113","author":"Leger","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2024.03.004_bib37","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/35007085","article-title":"PAR3 is a cofactor for PAR4 activation by thrombin","volume":"404","author":"Nakanishi-Matsui","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.jtha.2024.03.004_bib38","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/29325","article-title":"A\u00a0dual thrombin receptor system for platelet activation","volume":"394","author":"Kahn","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.jtha.2024.03.004_bib39","doi-asserted-by":"crossref","first-page":"10414","DOI":"10.1074\/jbc.M112.341438","article-title":"Mapping human protease-activated receptor 4 (PAR4) homodimer interface to transmembrane helix 4","volume":"287","author":"de la Fuente","year":"2012","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jtha.2024.03.004_bib40","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/jth.15669","article-title":"Human and mouse PAR4 are functionally distinct receptors: studies in novel humanized mice","volume":"20","author":"Renna","year":"2022","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.03.004_bib41","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/jth.15569","article-title":"Genetic deletion of platelet PAR4 results in reduced thrombosis and impaired hemostatic plug stability","volume":"20","author":"Lee","year":"2022","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.03.004_bib42","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1084\/jem.20112322","article-title":"Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in\u00a0vivo","volume":"209","author":"von Br\u00fchl","year":"2012","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jtha.2024.03.004_bib43","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1161\/ATVBAHA.118.310731","article-title":"Platelets drive thrombus propagation in a hematocrit and glycoprotein VI\u2013dependent manner in an in\u00a0vitro venous thrombosis model","volume":"38","author":"Lehmann","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtha.2024.03.004_bib44","doi-asserted-by":"crossref","first-page":"5112","DOI":"10.1038\/s41598-020-59526-x","article-title":"The distinctive structure and composition of arterial and venous thrombi and pulmonary emboli","volume":"10","author":"Chernysh","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtha.2024.03.004_bib45","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.thromres.2017.01.010","article-title":"Platelet function as a risk factor for venous thromboembolism in the Framingham Heart Study","volume":"151","author":"Puurunen","year":"2017","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2024.03.004_bib46","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1515\/cclm-2018-0909","article-title":"Circulating platelet-neutrophil aggregates as risk factor for deep venous thrombosis","volume":"57","author":"Zhou","year":"2019","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.jtha.2024.03.004_bib47","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1080\/09537104.2017.1406076","article-title":"Protease-activated receptor 4 activity promotes platelet granule release and platelet-leukocyte interactions","volume":"30","author":"Rigg","year":"2019","journal-title":"Platelets"},{"key":"10.1016\/j.jtha.2024.03.004_bib48","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12536","article-title":"D-dimer, thrombin generation, and risk of a first venous thrombosis in the elderly","volume":"5","author":"Wang","year":"2021","journal-title":"Res Pract Thromb Haemost"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783624001612?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783624001612?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T19:47:47Z","timestamp":1718826467000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783624001612"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S1538783624001612"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2024.03.004","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.12.01.569075","asserted-by":"object"}]},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A mouse model of the protease-activated receptor 4 Pro310Leu variant has reduced platelet reactivity","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2024.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}